Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Esophageal Neoplasms 3Stomach Neoplasms 2Glioma 2Warts 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Radiation Injuries 1Oligodendroglioma 1Melanoma 1Lung Neoplasms 1Esophagitis 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Heart Rate × Clear all
NCT05393258 2026-03-17

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Washington University School of Medicine

Phase NA Completed
13 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT06055517 2023-09-26

PULSAR

Centro di Riferimento Oncologico - Aviano

Phase NA Recruiting
29 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡